94 related articles for article (PubMed ID: 15861661)
1. [IL-1 family (IL-1alpha/beta, IL-1Ra, IL-18), IL-16, IL-17].
Okamura H
Nihon Rinsho; 2005 Apr; 63 Suppl 4():226-33. PubMed ID: 15861661
[No Abstract] [Full Text] [Related]
2. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.
Pirhonen J; Sareneva T; Kurimoto M; Julkunen I; Matikainen S
J Immunol; 1999 Jun; 162(12):7322-9. PubMed ID: 10358182
[TBL] [Abstract][Full Text] [Related]
3. [Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra)].
Hayashi H; Onozaki K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():60-4. PubMed ID: 16149452
[No Abstract] [Full Text] [Related]
4. [Interleukin-1 in pathogenesis of rheumatoid arthritis].
Iwakura Y
Nihon Rinsho; 2005 Jan; 63 Suppl 1():153-7. PubMed ID: 15799336
[No Abstract] [Full Text] [Related]
5. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
[TBL] [Abstract][Full Text] [Related]
6. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.
Chomarat P; Vannier E; Dechanet J; Rissoan MC; Banchereau J; Dinarello CA; Miossec P
J Immunol; 1995 Feb; 154(3):1432-9. PubMed ID: 7822808
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system.
Loppnow H; Werdan K; Reuter G; Flad HD
Eur Cytokine Netw; 1998 Dec; 9(4):675-80. PubMed ID: 9889413
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
10. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
Apte RN; Voronov E
Immunol Rev; 2008 Apr; 222():222-41. PubMed ID: 18364005
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 and the pathogenesis of inflammatory diseases.
Dinarello CA
Semin Nephrol; 2007 Jan; 27(1):98-114. PubMed ID: 17336692
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and its inhibitors: implications for disease biology and therapy.
Estrov Z; Kurzrock R; Talpaz M
Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
[TBL] [Abstract][Full Text] [Related]
14. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10.
MacDonald KP; Pettit AR; Quinn C; Thomas GJ; Thomas R
J Immunol; 1999 Nov; 163(10):5599-607. PubMed ID: 10553089
[TBL] [Abstract][Full Text] [Related]
15. Imbalance production between interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma.
Mao XQ; Kawai M; Yamashita T; Enomoto T; Dake Y; Sasaki S; Kataoka Y; Fukuzumi T; Endo K; Sano H; Aoki T; Kurimoto F; Adra CN; Shirakawa T; Hopkin JM
Biochem Biophys Res Commun; 2000 Sep; 276(2):607-12. PubMed ID: 11027520
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.
Dinarello CA
Blood; 2011 Apr; 117(14):3720-32. PubMed ID: 21304099
[TBL] [Abstract][Full Text] [Related]
17. [Antibody to IL-1 or IL-15].
Akama H
Nihon Rinsho; 2007 Jul; 65(7):1227-30. PubMed ID: 17642236
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
Mehraban F; Kasturi S
Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
